The effects of repetitive alkaline/acid extractions of Saccharomyces cerevisiae cell wall on antioxidative and bifidogenic efficacy

International Journal of Food Science and Technology

Volumn 47, Issue 2, 2012, Pages 369-375

  Laugier, Olga B ^a   Spasić, Snezana D ^a   Mandić, Vesna ^b   Jakovljević, Dragica ^a   Vrvić, Miroslav M ^a,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b University Clinic for Obstetrics and Gynecology Narodni Front   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Alkaline acid extraction; Antioxidant; Baker's yeast; Bifidogenic efficacy; Digestibility

Indexed keywords

ANTI OXIDATIVE ACTIVITY; ANTIOXIDANT; ANTIOXIDATIVE CAPACITY; ARTIFICIAL SALIVA; BAKER'S YEAST; BIFIDOGENIC EFFICACY; CELL WALLS; DIGESTIBILITY; GLUCAN CONTENT; GLUCANS; HYDROXYL RADICALS; PREBIOTICS; S.CEREVISIAE; SACCHAROMYCES CEREVISIAE CELLS;

CELLS; FREE RADICALS;

YEAST;

SACCHAROMYCES CEREVISIAE;

EID: 84855866191     PISSN: 09505423     EISSN: 13652621     Source Type: Journal    
DOI: 10.1111/j.1365-2621.2011.02849.x     Document Type: Article

References (42)

1. Adams, M.R. & Hall, C.J. (1988). Growth inhibition of food bone pathogens by lactic, acetic acids and their mixtures. International Journal of Food Science and Technology, 23, 287-292.
2. Agostoni, C. & Domellof, M. (2005). Infant formulae: from ESPGHAN recommendations towards ESPGHAN-coordinated global standards. Journal of Pediatric Gastroenterology and Nutrition, 41, 580-583.
3. Akramiene, D., Aleksandraviciene, C., Grazeliene, G. et al. (2010). Potentiating effect of beta-glucans on photodynamic therapy of implanted cancer cells in mice. Tohoku Journal of Experimental Medicine, 220, 299-306.
4. Alles, M., Scholtens, P. & Bindels, J. (2004). Current trends in the composition of infant milk formulas. Current Opinion in Pediatrics, 14, 51-63.
5. Angeli, J.P.F., Ribeiro, L.R., Bellini, M.F. & Mantovani, M.S. (2006). Anticlastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells. Human and Experimental Toxicology, 25, 319-324.
6. Aura, A.M. (2005). In Vitro Digestion Models for Dietary Phenolic Compounds. Pp. 233-121. Helsinki, Finland: VTT Publications.
7. Boehm, G., Liedestri, M., Casetta, P. et al. (2002). Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of fecal bifidobacteria in preterm infants. Archives of Disease in Childhood Fetal & Neonatology, 86, F178-F181.
8. Chorvatovicova, D. (1991). Effects of glucan on micromuceli induced by Co60 in mice. Strahlenther Onkologie, 167, 612-614.
9. Collins, C.H., Lyne, P.M., Grange, J.M. & Falkinham, J.O. (2004). Collins and Lyne's Microbiological Methods. Pp. 144-152. London, UK: Hodder Arnold.
10. DiLuzio, N.R., Williams, D.L., McNamee, R.B., Edwards, B.F. & Kitahama, A. (1979). Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. International Journal of Cancer, 24, 773-779.
11. Food and Drug Administration (1996) Food additives permitted for direct addition to food for human consumption: Curdlan. 21 CFR 172. Federal Register, 61, 65941.
12. Gibson, G. (2004). Fibre and effects on probiotics (a prebiotic concept). Clinical Nutrition Supplements, 1, 25-31.
13. Gibson, G.R. & Wang, X. (1994). Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology, 77, 412-420.
14. Harmsen, H.J.M., Raangs, G.C., Franks, A.H., Wildeboer-Veloo, A.C.M. & Welling, G.W. (2002). The effect of the prebiotic inulin and the probiotic Bifidobacterium longum on the fecal microflora of healthy volunteers measured by FISH and DGGE. Microbial Ecology in Health and Disease, 14, 211-219.
15. Herre, J., Gordon, S. & Brown, G.D. (2004). Dectin-1 and its role in the recognition of β-glucans by macrophages. Molecular Immunology, 40, 869-876.
16. Jaskari, J., Kontula, P., Siitonen, A., Jousimies-Somer, H., Mattila-Sandholm, T. & Poutaten, K. (1998). Oat β-glucan and xylan hydrolisates as selective substrates for Bifidobacterium and Lactobacillus strains. Applied Microbiology and Biotechnology, 49, 175-181.
17. Kaiser, A.B. & Kernodle, D.S. (1998). Synergism between poly-(1-6)-β-d-glucopyranosyl-(1-3)-β-d-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model. Antimicrobial Agents and Chemotherapy, 42, 2449-2451.
18. Kim, S.H., Lee, D.H. & Meyer, D. (2007). Supplementation of infant formula with native inulin has a prebiotic effect in formula-fed babies. Asia Pacific Journal of Clinical Nutrition, 16, 172-177.
19. Krizkova, L., Zitnanova, D., Mislovicova, D. et al. (2006). Antioxidant and antimutagenic activity of mannan neoglycoconjugates: mannan-human serum albumin and mannan-penicillin G acylase. Mutation Research, 606, 72-79.
20. Liang, J., Melican, D., Cafro, L. et al. (1998). Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. International Journal of Immunopharmacology, 20, 595-614.
21. Lipke, P.N. & Ovalle, R. (1998). Cell wall architecture in yeast: new structure and new challenges. Journal of Food Science, 39, 368-370.
22. Lugonja, N.M., Martinov, O.B., Rašović, M.R., Spasić, S.D., Gojgić, G.Dj. & Vrvić, M.M. (2010). A comparative investigation of an in vitro and clinical test of the bifidogenic effect of an infant formula. Journal of Clinical Biochemistry and Nutrition, 47, 208-216.
23. McWilliam Leitch, E.C. & Stewart, C.S. (2002). Escherichia coli O157 and non-O157 isolates are more susceptible to l-Lactate than to d-Lactate. Applied and Environmental Microbiology, 68, 4676-4678.
24. Minato, K., Kawakami, S., Nomura, K., Thushida, H. & Mizuno, M. (2004). An exo β-1, 3-glucanase synthesized de novo degrades lentinan during storage of Lentinule edodes and diminishes immunomodulating activity of the mushroom. Carbohydrate Polymers, 56, 279-286.
25. Mitsou, E.K., Panopoulou, N., Turunen, K., Spiliotis, V. & Kyriacou, A. (2010). Prebiotic potential of barley derived β-glucan at low intake levels: a randomised, double-blinded, placebo-controlled clinical study. Food Research International, 43, 1086-1092.
26. Moon, N.J. (1983). Inhibition of the growth of acid tolerant yeasts by acetate, lactate and their synergistic mixtures. Journal of Applied Bacteriology, 55, 453-460.
27. Nebra, Y. & Blanch, A. (1999). A new selective medium for Bifidobacetrium spp. Applied and Environmental Microbiology, 65, 5173-5176.
28. Nguyen, T.H., Fleet, G.H. & Rogers, P.L. (1998). Composition of the cell walls of several yeast species. Applied Microbiology and Biotechnology, 50, 206-212.
29. Salminen, S., Bouley, C. & Boutron-Ruault, M.C. (1998). Functional food science and gastrointestinal physiology and function. British Journal of Nutrition, 80, 147-171.
30. Saluk-Juszczak, J., Krolewska, K. & Wachowicz, B. (2010). Β-glucan fromSaccharomyces cerevisiaeas a blood platelet antioxidant. Platelets, 21, 37-43.
31. Slamenova, D., Labaj, J., Krizkova, L. et al. (2003). Protective effects of fungal β-d-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Letters, 198, 153-160.
32. Snart, J., Bibiloni, R., Grayson, T. et al. (2006). Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum. Applied and Environmental Microbiology, 72, 1925-1931.
33. Song, M. & DiLuzio, N.R. (1979). Yeast glucan and immunotherapy of infectious diseases. In: Lysosomes in Biology and Pathology, Vol 6 (edited by J.T. Dingle, P.J. Jacques & I.W. Shaw). Pp. 533-547. Amsterdam, Netherlands: North Holland Press.
34. Spasojević, I., Mojović, M., Blagojević, S. et al. (2009). Relevance of the capacity of phosphorylated fructose to scavenge the hydroxyl radical. Carbohydrate Research, 344, 80-84.
35. Thammakiti, S., Suphantharika, M., Phaesuwan, T. & Verduyn, C. (2004). Preparation of spent brewer's yeast β-glucans for potential applications in the food industry. International Journal of Food Science and Technology, 39, 21-29.
36. Tohamy, A.A., El-Ghor, A.A., El-Nahas, S.M. & Noshy, M.M. (2003). Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutation Research, 10, 541.
37. Tsiapali, E., Whaley, S., Kalbfleisch, J., Ensley, H.E., Browder, W.I. & Williams, D.L. (2001). Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radical Biology & Medicine, 30, 393-402.
38. Vetvicka, V. & Vancikova, Z. (2010). Anti-stress action of several-orally given β-glucans. Biomedical papers of the Medical Faculty of the University Palacky, 154, 235-238.
39. Yamamoto, Y., Takahashi, Y., Kawano, M. et al. (1999). In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats. Journal of Nutritional Biochemistry, 10, 13-18.
40. Zeković, D.B., Kwiatkowski, S., Vrvić, M.M., Jakovljević, D. & Moran, C.A. (2005). Natural modified (1→3)-β-glucans in health promotion and disease alleviation. Critical Reviews in Biotechnology, 25, 205-230.
41. Živković, J., Zeković, Z., Mujić, I. et al. (2009). EPR spin-trapping and spin-probing spectroscopy in assessing antioxidant properties: example on extracts of catkin, leaves, and spiny burs of Castanea sativa. Food Biophysics, 4, 126-133.
42. Zlatković, D., Jakovljević, D., Zeković, Dj. & Vrvic, M.M. (2003). A glucan from active dry baker's yeast (Saccharomyces cerevisiae): chemical and enzymatic investigation of the structure. Journal of the Serbian Chemical Society, 68, 805-809.